Meeting
2021 ASCO Quality Care Symposium
Differences by race in systemic oncologic end-of-life (EOL) care among patients with cancer.
Authors
Kerin B. Adelson
Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven Health, New Haven, CT
Kerin B. Adelson, Xiaoliang Wang, Mustafa Ascha, Rebecca A. Miksad, Timothy N Showalter, Gregory Sampang Calip, Cary Philip Gross, Maureen Canavan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience
Track
Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science
Sub Track
Health Disparities
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 137)
DOI
10.1200/JCO.2020.39.28_suppl.137
Abstract #
137
Poster Bd #
E3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).
First Author: Maureen Canavan
Poster
2021 ASCO Quality Care Symposium
Trends in end-of- life (EOL) systemic oncologic treatment in contemporary clinical practice: Insights from real-world data.
First Author: Maureen Canavan
Poster
2024 ASCO Annual Meeting
Systemic anti-cancer therapy and cost at end of life: A SEER Medicare analysis.
First Author: Kerin B. Adelson
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Benefit of immune checkpoint inhibitors (ICI) for patients with advanced esophageal squamous cell carcinoma and low PD-L1 expression: A systematic review and meta-analysis.
First Author: Mario Machado Lopes